S&T Bancorp Reports Mixed 2025 Results: Increased Earnings & $100M Share Repurchase Offset by Deteriorating Asset Quality
STBA sits 36% above its 52-week low of $30.84 on elevated volume (1.9× avg).
Summary
S&T Bancorp reported higher net income and EPS for 2025 and authorized a new $100 million share repurchase program. However, these positives are tempered by a significant increase in nonaccrual loans and provision for credit losses, alongside a decrease in the ACL.
Key Events · Earnings and Guidance · STBA
-
Increased Earnings
Net income rose to $134.2 million in 2025 from $131.3 million in 2024, with diluted EPS increasing to $3.49 from $3.41. Net interest income also grew by 4.57% to $350.1 million.
-
New Share Repurchase Program
The Board authorized a new $100 million share repurchase program on January 21, 2026, replacing a prior $50 million plan. As of February 25, 2026, $37.2 million has already been repurchased under the new program.
-
Deteriorating Asset Quality
Nonaccrual loans significantly increased to $55.6 million at December 31, 2025, from $27.9 million in 2024, primarily due to three commercial relationships totaling $25.3 million. Net loan charge-offs also rose to $14.5 million from $8.3 million.
-
Allowance for Credit Losses Decreased Amidst Concerns
The Allowance for Credit Losses (ACL) decreased to $93.2 million from $101.5 million, despite the rise in nonaccrual loans and charge-offs. The auditor identified the ACL as a 'Critical Audit Matter' due to the high degree of subjectivity in its estimation.
Analysis · STBA · Finance
S&T Bancorp's 2025 annual report presents a mixed financial picture. While the company reported increased net income and diluted EPS, and authorized a substantial $100 million share repurchase program (with $37.2 million already executed), asset quality showed significant deterioration. Nonaccrual loans nearly doubled, and the provision for credit losses increased substantially. This is particularly concerning given a simultaneous decrease in the Allowance for Credit Losses (ACL), which the auditor highlighted as a 'Critical Audit Matter' due to its subjective nature. The strong capital ratios provide a buffer, but the trends in asset quality warrant close monitoring.
At the time of this filing, STBA was trading at $41.81 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $30.84 to $44.91. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.